Optimising the M72/AS01E tuberculosis vaccine candidate phase 3 trial based on the phase 2b trial results

{"title":"Optimising the M72/AS01E tuberculosis vaccine candidate phase 3 trial based on the phase 2b trial results","authors":"Katie D. Dale , Justin T. Denholm","doi":"10.1016/j.vaccine.2025.126816","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"49 ","pages":"Article 126816"},"PeriodicalIF":4.5000,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X25001136","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}